Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -9.68% |
| 2024 | -7.57% |
| 2023 | -8.48% |
| 2022 | -7.99% |
| 2021 | 40.33% |
| 2020 | 35.73% |
| 2019 | 109.87% |
| 2018 | 161.23% |
| 2017 | 75.39% |
| 2016 | 67.36% |